M
Masaaki Miyata
Researcher at Tohoku University
Publications - 51
Citations - 1502
Masaaki Miyata is an academic researcher from Tohoku University. The author has contributed to research in topics: Bile acid & Farnesoid X receptor. The author has an hindex of 21, co-authored 51 publications receiving 1331 citations.
Papers
More filters
Journal ArticleDOI
Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity.
Hirotaka Kitada,Masaaki Miyata,Toshifumi Nakamura,Aki Tozawa,Wataru Honma,Miki Shimada,Kiyoshi Nagata,Christopher J. Sinal,Grace L. Guo,Frank J. Gonzalez,Yasushi Yamazoe +10 more
TL;DR: Results indicate hydroxysteroid sulfotransferase-mediated LCA sulfation as a major pathway for protection against LCA-induced liver damage.
Journal ArticleDOI
Mechanism of 7,12-dimethylbenz[a]anthracene-induced immunotoxicity: role of metabolic activation at the target organ.
TL;DR: The results suggest the involvement of mEH in splenic activation of DMBA for immunotoxicity and the difference for the DMBA-induced lymphoid toxicity between spleen and thymus.
Journal ArticleDOI
Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin.
Hitoshi Ando,Shuichi Tsuruoka,Hayato Yanagihara,Koh-ichi Sugimoto,Masaaki Miyata,Yasushi Yamazoe,Toshinari Takamura,Shuichi Kaneko,Akio Fujimura +8 more
TL;DR: GFJ increased the mean AUC(0-24) of atorvastatin acid by 83% (95% CI 23-144%) and that of pitavastatin Acid by 13% (-3 to 29%).
Journal ArticleDOI
Isolation and Characterization of a New Major Intestinal CYP3A Form, CYP3A62, in the Rat
TL;DR: Despite clear detection of CYP3A62, no detectable levels of CYp3A1 and CYP4A2 proteins, as well as those of mRNAs, were found in the intestinal tract, therefore, CYP 3A62 may play major roles together with CYP2A9 and CYB3A18 in endogenous or exogenous detoxification at the absorption site.
Journal ArticleDOI
Administration of Ampicillin Elevates Hepatic Primary Bile Acid Synthesis through Suppression of Ileal Fibroblast Growth Factor 15 Expression
TL;DR: Results suggest that ABPC administration elevates hepatic primary bile acid synthesis, at least in part, through suppression of ileal FGF15 expression.